Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis

Eric S Surrey; Kaylen M Silverberg; Mark W Surrey; M. Surrey; William B Schoolcraft

doi:10.1016/s0015-0282(02)03373-3

Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis

Eric S Surrey, Kaylen M Silverberg, Mark W Surrey, M. Surrey, William B Schoolcraft

Fertility and Sterility · 2002 · vol. 78(4) , pp. 699–704 · doi:10.1016/s0015-0282(02)03373-3 · PMID:12372443 · W2116648077

article OA: bronze CC0 ⤵ 168 in-corpus citations

🔓 Open OA copy View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This study investigated the impact of extended GnRH agonist treatment on IVF-ET success rates in women diagnosed with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Embryo Transfer Endometriosis Fertilization in Vitro Infertility, Female Leuprolide Treatment Outcome Adult Embryo Implantation Endometriosis Female Humans Infertility, Female Infertility, Female Leuprolide Ovulation Induction Pregnancy Prospective Studies

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (30)

Cited by (50)

Source provenance

europepmc: last seen: 2026-06-11T06:19:48.454388+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:13:01.552487+00:00

License: CC0 · commercial use OK

[1] Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex

[2] Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: A randomized clinical trial via openalex

[3] Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis via openalex

[4] Direct effects of medroxyprogesterone acetate, danazol, and leuprolide acetate on endometrial stromal cell proliferation in vitro via openalex

[5] Effect of Peritoneal Fluid From Endometriosis Patients on Endometrial Stromal Cell Proliferation In Vitro via openalex

[6] Efficacy of danazol treatment for minimal endometriosis in infertile women. A prospective, randomized study. via openalex

[7] Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study via openalex

[8] Endometriosis and Infertility via openalex

[9] Endometriosis: a stage by stage analysis—the role of in vitro fertilization via openalex

[10] Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro via openalex

[11] High rates of pregnancy after long-term down-regulation of women with severe endometriosis via openalex

[12] Impact of stage iii–iv endometriosis on recipients of sibling oocytes: matched case-control study via openalex

[13] Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study via openalex

[14] Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex

[15] Medical management of endometriosis and infertility via openalex

[16] Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis via openalex

[17] Natural cytotoxicity and gnrh agonist administration in advanced endometriosis: positive modulation on natural killer activity via openalex

[18] Pretreatment with gonadotrophin releasing hormone (GnRH) analogue prior to in vitro fertilisation for patients with endometriosis via openalex

[19] Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain via openalex

[20] Results of IVF in patients with endometriosis: the severity of the disease does not affect outcome, or the incidence of miscarriage via openalex

[21] The impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer via openalex

[22] The value of pre-treatment with gonadotrophin releasing hormone (GnRH) analogue in IVF-ET therapy of severe endometriosis via openalex

[23] Tissue Inhibitor of Metalloproteinase-1 Concentrations are Attenuated in Peritoneal Fluid and Sera of Women with Endometriosis and Restored in Sera by Gonadotropin-Releasing Hormone Agonist Therapy via openalex

[24] Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group. via openalex

[25] W2396126095 via openalex

[26] W2394991755 via openalex

[27] W2010252495 via openalex

[28] W2001051801 via openalex

[29] W2477008945 via openalex

[30] W6813879573 via openalex